Review Indemnification and Escrow in an ABA Practice Sale

To review indemnification and escrow in an ABA practice sale, connect each representation, warranty, covenant, and known exposure to the loss it covers, who bears it, the survival period, applicable baskets and caps, notice and defense procedures, evidence, exclusions, payment source, and release schedule. Read escrow beside the seller note, earnout, working-capital true-up, insurance, disclosure schedules, and tax allocation so one issue is not deducted twice or left without a practical remedy.

These provisions are the transaction's after-closing map

Most sellers spend months negotiating price and only later feel the weight of indemnification. The provision answers a practical question: if a statement was inaccurate, a promise was not performed, or a defined pre-closing exposure produces a loss after closing, who is responsible and how is the claim handled? Escrow is one possible funding source, not the definition of responsibility itself.

Learning how to review indemnification and escrow in an ABA practice sale is easier when the legal vocabulary is translated into events the owner recognizes. A payer recoupment, unrecorded liability, tax notice, privacy incident, employee claim, lease problem, or ownership dispute can each travel through a different part of the agreement. The goal is a map that the parties can follow, not a stack of impressive terms that no operator can apply.

Start with the promise before debating the remedy

Read the representations and warranties line by line with the disclosure schedules. Identify what is stated, which entity and period it covers, the knowledge and materiality qualifiers, the records supporting it, and any exceptions disclosed. Then review the covenants, including obligations before closing, after closing, and around transition. A broad indemnity cannot repair an inaccurate factual process; the practice still needs a disciplined way to investigate and disclose.

The SBA sell-your-business guidance says a sales agreement should be attorney-reviewed and comprehensive, including assets, liabilities, adjustments, fees, and information access. It supplies no healthcare indemnity language or market terms. Qualified transaction counsel should draft and explain the actual agreement, while finance, payer, employment, privacy, clinical, tax, and operating leaders verify the facts in their own lanes.

Build a simple matrix of covered events

For each representation, warranty, covenant, and specific indemnity, create a row showing the protected party, breach or trigger, covered loss, exclusions, survival, basket, cap, funding source, notice route, defense control, and evidence owner. Add a cross-reference to the disclosure schedule and data-room file. This turns a long agreement into a working model without replacing legal review.

Keep ordinary representations separate from fundamental matters, taxes, purchase-price adjustments, fraud or intentional misconduct, and named known exposures. The categories may have different limits, but their labels and enforceability depend on the signed documents and law. There is no government-prescribed ABA basket, cap, survival period, fraud carveout, or escrow percentage. Be wary of anyone presenting a single number as universal market practice.

Define loss and causation before modeling a cap

The word “loss” may include damages, liabilities, judgments, settlements, fines, interest, professional fees, investigation costs, lost profits, diminution in value, multiples, or other measures, with negotiated inclusions and exclusions. Read the definition beside causation, foreseeability, mitigation, insurance recovery, tax benefit, materiality scrape, anti-sandbagging or sandbagging language, and rules against duplicate recovery.

Model a few concrete events. If a pre-closing claim is recouped after closing, is the covered amount the payer debit, the cost of appeal, the associated tax effect, lost future revenue, or some combination? If a disclosed issue worsens, what part was assumed in price? Counsel and subject-matter advisers should answer from the documents and applicable authority, not from a generic transaction checklist.

Escrow, holdback, and setoff are different levers

An escrow places funds with a third party under agreed release and claim procedures. A holdback may remain with the buyer. Setoff may allow the buyer to reduce another payment, such as a seller note or earnout. Representation-and-warranty insurance may shift some risk but brings its own policy, retention, exclusions, diligence, notice, and claims process. Each mechanism changes collection risk, control, cost, and leverage.

Map every source on one page. Show the amount, holder, permitted claims, release dates, partial releases, investment earnings, fees, disputed-claim reserves, and what happens after a claim is resolved. If the buyer can reserve a large amount in escrow and also withhold the same amount from a note, the documents need an explicit rule against double recovery. If escrow is the exclusive remedy, list the exceptions rather than assuming them.

The claims procedure matters as much as the cap

A usable procedure identifies how a claim is delivered, what detail and evidence it includes, when objections are due, how undisputed amounts are paid, where funds remain during a dispute, and which forum decides the issue. For third-party claims, address who controls the defense, selects counsel, receives information, approves settlement, protects privilege, and handles conflicts. A party that bears the economic loss but cannot influence the defense may face a serious mismatch.

Notice deadlines should be read beside survival periods. Ask whether a timely notice preserves a claim after the survival date and what happens when the amount is not yet known. Also distinguish an accounting expert's narrow role in a working-capital dispute from a court, arbitrator, or other forum that may decide contract, fraud, privacy, employment, payer, or clinical questions.

ABA diligence should follow the source of exposure

Payer contracts, enrollments, authorizations, documentation, coding, billing, refunds, credit balances, clinical records, supervision, workforce classifications, leases, taxes, licenses, and privacy incidents do not share one evidence path. Assign each representation to a qualified owner who can inspect current written sources, reconcile records, document exceptions, and describe unresolved facts. The transaction team should not turn uncertainty into a clean representation by drafting around it.

The OIG General Compliance Program Guidance is voluntary and nonbinding. Its themes of leadership, risk assessment, reporting, incentives, auditing, investigation, and corrective action can inform the diligence process. It does not decide whether a claim was payable, a refund is due, or a seller must indemnify a buyer. Those questions require the facts, governing payer or legal authority, and the signed agreement.

Protect clinical judgment from private deal pressure

A seller may fear that reporting a concern will reduce proceeds, while a buyer may fear inheriting an undisclosed problem. The answer is a credible review and disclosure process, not pressure on clinicians to reinterpret history. Preserve records, route questions to qualified professionals, and use controlled correction or late-entry processes when appropriate. Never backdate, overwrite, manufacture, or change clinical content to make a representation easier to give.

The BACB Ethics Code applies to certificants within its scope and addresses truthfulness, competence, conflicts, documentation, supervision, client welfare, and transitions. The CASP organizational-guidelines overview shows a cross-functional business, clinical, quality, human-resources, and risk-management frame, while its detailed material is separate. Neither source supplies transaction terms. They reinforce that clinical and operational facts should be handled by people with the right authority.

Privacy access needs a narrower route than the data room

The current health-care-operations definition in 45 CFR 164.501 includes certain sale, transfer, merger, consolidation, and related due-diligence activities when the stated conditions apply. It does not authorize unlimited access for every bidder, insurer, broker, lawyer, accountant, lender, or affiliate. HHS business-associate guidance also explains that some professional and administrative services involving PHI may create business-associate relationships.

Design the request process around purpose and minimum necessary data. Use aggregates, redaction, de-identification, staged access, logging, expiration, and return or deletion where appropriate. If a post-closing claim requires client-level evidence, privacy and security leaders should approve the party, authority, scope, safeguards, retention, and transfer route before information is shared.

Tax treatment can change when consideration changes

Escrow and indemnification can affect when and how a seller receives consideration, but the word escrow does not produce one tax result. IRS Publication 537 discusses installment sales and explains that some escrow arrangements can be treated as payment while a substantial restriction may matter. That discussion is general and should not be applied to a transaction escrow without qualified advice.

For covered asset acquisitions, the Form 8594 instructions explain that a later increase or decrease in consideration may require supplemental reporting and reallocation. The IRS sale-of-a-business page provides broader asset-sale orientation. Entity structure, claim type, allocation, interest, insurance, legal fees, state tax, and settlement wording can all matter. Tax advisers should review the purchase agreement, escrow agreement, and claim resolution together.

A fictional claim uncovers three overlapping deductions

Harbor Fern ABA is fictional. The buyer discovers a pre-closing payer credit balance after closing and sends a claim. The first draft permits the buyer to reserve the full amount in escrow, stop the same amount of seller-note payments, and include the balance in a working-capital adjustment. The seller objects, but the documents do not clearly prevent the overlap.

The parties trace the balance to its source, assign it once under the agreed purchase-price and indemnity rules, preserve the payer-response process, and release the unrelated escrow amount. They also clarify how professional fees and later payer corrections are handled. The example does not decide liability. It shows why every claimed dollar needs one factual basis, one calculation path, and one recovery path.

Release mechanics should work on an ordinary day

An escrow release may occur automatically, on joint instruction, after an agent receives certification, or only after stated conditions. Ask who calendars the date, prepares the instruction, verifies unresolved claims, pays agent fees, and confirms the transfer. A well-negotiated economic term can still fail operationally if no one owns the paperwork or the agreement lets a vague notice reserve the entire balance indefinitely.

Run a tabletop exercise for no claims, one resolved claim, one disputed estimate, and a third-party claim that continues beyond the main release date. Confirm partial release, tax reporting, contact details, bank verification, fraud controls, and record retention. The exercise often reveals missing process language while the parties still have leverage to fix it.

Finish with a risk map the owner can explain

Knowing how to review indemnification and escrow in an ABA practice sale does not require the owner to become transaction counsel. It requires enough understanding to ask what was promised, what event creates responsibility, what loss is covered, which limit applies, where payment comes from, how a dispute runs, and when remaining funds are released. If those questions cannot be answered in plain language, the documents are not ready for a signature meeting.

Preserve a final matrix, disclosure record, funds map, claims calendar, insurance summary, tax advice, privacy route, clinical and compliance escalation path, and list of unresolved questions. Fairness is not a universal cap or escrow percentage. It is a negotiated allocation the parties understand, supported by facts they were willing to test.

How to Review Indemnification and Escrow in an ABA Practice Sale